Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often? Authors' reply

Affiliations

¹ Department of Internal Medicine, Division of Gastroenterology and Hepatology, Loma Linda University Medical Center, Loma Linda, California.
² Department of Internal Medicine, Division of Gastroenterology, Michigan State University College of Human Medicine, Southfield, Michigan.
³ Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.

Free article

Comment

Andrew P Wright et al. Aliment Pharmacol Ther. 2019 Sep.

Free article

. 2019 Sep;50(5):613.

doi: 10.1111/apt.15448.

¹ Department of Internal Medicine, Division of Gastroenterology and Hepatology, Loma Linda University Medical Center, Loma Linda, California.
² Department of Internal Medicine, Division of Gastroenterology, Michigan State University College of Human Medicine, Southfield, Michigan.
³ Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.

No abstract available

Comment on

Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis.
Wright AP, Piper MS, Bishu S, Stidham RW. Wright AP, et al. Aliment Pharmacol Ther. 2019 Jun;49(12):1474-1483. doi: 10.1111/apt.15263. Epub 2019 Apr 29. Aliment Pharmacol Ther. 2019. PMID: 31035308 Free PMC article.
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often?
Samaan MA, Powell N, Irving PM. Samaan MA, et al. Aliment Pharmacol Ther. 2019 Aug;50(4):472-473. doi: 10.1111/apt.15393. Aliment Pharmacol Ther. 2019. PMID: 31359485 No abstract available.